Cubist Systematic Strategies’s SeaStar Medical ICU Stock Holding History

Cubist Systematic Strategies’s Portfolio ICU Stock Details ICU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-42	Closed	-$5.46K	–	3614
2023 Q2	$5.46K	Buy	+42	New	+$12.6K	﹤0.01%	3301

Other funds holding ICU

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SWA

SFMG Wealth Advisors Plano, Texas $1.48B AUM 15.85% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return

FVWA

Foster Victor Wealth Advisors Greenville, South Carolina $1.75B AUM 18.02% 1-Year Est. Return

WAM

Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Cubist Systematic Strategies's ICU Position: Q3 2023 in Review

Cubist Systematic Strategies sold out of SeaStar Medical (ICU) in Q3 2023, closing a stake of 42 shares — an estimated $5.46K sold.

Cubist Systematic Strategies first reported a position in ICU in Q2 2023 and held it in 1 quarter. The position peaked at $5.46K in Q2 2023. 12 funds tracked by Wall St. Rank hold ICU as of Q3 2023.

Cubist Systematic Strategies reported no remaining SeaStar Medical position as of Q3 2023 after selling out during the quarter.
Cubist Systematic Strategies sold 42 SeaStar Medical shares in Q3 2023, an estimated $5.46K.
Cubist Systematic Strategies first reported a position in SeaStar Medical in Q2 2023 and held it in 1 quarter.
Cubist Systematic Strategies's SeaStar Medical position peaked at $5.46K in Q2 2023.
12 funds tracked by Wall St. Rank held SeaStar Medical as of Q3 2023.

Based on Cubist Systematic Strategies's 13F filing for Q3 2023, filed 14 Nov 2023.